2021-03-04 General

Vaccines Canada is probably going to approve the Johnson and Johnson COVID-19 vaccine in the next few days. That will make four vaccines, five if you count the Serum Institute of India’s vaccine as different from AstraZeneca. There is an article in the Economist which says that the differences in reported vaccine efficacy is really… Continue reading 2021-03-04 General

2021-03-03 General

Vaccines The Novavax vaccine — which had ~90% efficacy against B.1.1.7 — had only 60% efficacy against HIV-negative patients, most of whom had B.1.351. As a side effect, the study showed that having had COVID Classic didn’t give you any protection against B.1.351. Yikes. There is a report that, while rare, some delayed (5 days… Continue reading 2021-03-03 General

2021-03-02 General

Variants The New York Times has an article talking about the naming of variants. Basically, it’s hard to make strain names memorable while also avoiding place names, people’s names, and names of animals. 🙁 There are a few ways that scientists figure out how resistant a variant is to a vaccine. One is to look… Continue reading 2021-03-02 General